Yurpeak Kwikpen 7.5mg Pre Filled Pen Of 2.4ml Solution For Injection

• Abdominal pain
• Constipation
• Indigestion
• Nausea
• Diarrhea
• Vomiting

Other General Warnings

• You have a history of pancreatitis.
• You experience severe abdominal pain, nausea, or vomiting, which could indicate pancreatitis.
• You have type 2 diabetes and are taking insulin or a sulfonylurea, as you may be at an increased risk of hypoglycemia.
• You experience frequent nausea, vomiting, or diarrhoea, which may lead to dehydration and kidney issues.
• You have kidney disease, have had a kidney transplant, or have liver disease.
• You are elderly, especially if you are over 85 years old, as there is limited data on safety in this age group.
• You have a disease of the gallbladder or experience symptoms such as abdominal pain, yellowing of the skin or eyes (jaundice), clay-coloured stools, and fever.
• You have severe gastrointestinal disease, including gastroparesis (delayed emptying of the stomach due to reduced movement), as this injection has not been studied in such patients.
• You have eye problems, such as diabetic retinopathy or diabetic macular oedema, as this injection should be used cautiously in these conditions.
• You are scheduled for a procedure requiring general anaesthesia or deep sedation, as there is an increased risk of pulmonary aspiration.
• You notice any unusual changes in your vision while using this injection.

• Store Yurpeak 7.5mg KwikPen in a refrigerator at a temperature between 2°C to 8°C.
• Do not freeze Yurpeak, and do not use this medicine if it has been frozen.
• Store it in the original carton to protect it from light.

• To help keep your blood sugar levels steady, take Yurpeak 7.5mg KwikPen on the same day each week. Setting a reminder can help you stay on track.
• Rotate your injection sites (such as the abdomen, thigh, or upper arm) weekly to prevent skin irritation, bruising, or lumps.
• Regularly check your blood sugar to monitor for signs of low blood sugar, especially if you are on other diabetes medications.
• Eat small, frequent, and balanced meals, and avoid greasy or heavy foods to minimise nausea. Make sure to stay hydrated by drinking plenty of water, especially if you experience nausea, vomiting, or diarrhoea.
• Be aware of serious side effects such as intense stomach pain, signs of pancreatitis (like pain radiating to the back with nausea or fever), or allergic reactions. Contact your doctor immediately if any of these occur.
• Yurpeak 7.5mg KwikPen may interfere with oral contraceptives. To prevent unintended pregnancy, use a backup birth control method (such as condoms) or switch to a non-oral contraceptive for four weeks after starting treatment and for four weeks after any dose increase.
• Inform your doctor or surgeon that you’re using this injection if you have surgery scheduled, as it may slow down how your stomach empties and increase the risk of complications during anaesthesia.

Overdose

Missed a Dose

How Does It Work?

Interactions with other medicines

• Taking oral medications with a narrow therapeutic index, such as warfarin or digoxin, may be affected by tirzepatide, as it can alter their absorption.
• Using medications that require a rapid onset of action might be problematic since tirzepatide may delay their effects.
• Relying on oral contraceptives may be risky, as tirzepatide could reduce their effectiveness. It is advisable to consider switching to a non-oral contraceptive method or to use additional protection for four weeks after starting tirzepatide or increasing its dose.
• Frequent paracetamol use may be affected by tirzepatide, which may delay its absorption; however, no dose adjustment is typically necessary.
• Taking oral medications with a narrow therapeutic index, such as warfarin or digoxin, may be affected by tirzepatide, as it can alter their absorption.
• Using medications that require a rapid onset of action might be problematic since tirzepatide may delay their effects.
• Relying on oral contraceptives may be risky, as tirzepatide could reduce their effectiveness. It is advisable to consider switching to a non-oral contraceptive method or to use additional protection for four weeks after starting tirzepatide or increasing its dose.
• Frequent paracetamol use may be affected by tirzepatide, which may delay its absorption; however, no dose adjustment is typically necessary.